Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

Introduction: Recurrence of HCV infection in patients with chronic hepatitis C virus (HCV) at the time of liver transplantation is nearly universal and reduces the likelihood of graft and patient survival. Materials and methods: We evaluated outcomes of 17 patients (16 with HCV genotype 1 and 1 with...

Full description

Bibliographic Details
Main Authors: Eric M. Yoshida, Paul Kwo, Kosh Agarwal, Christophe Duvoux, François Durand, Markus Peck-Radosavljevic, Leslie Lilly, Bernard Willems, Hugo Vargas, Princy Kumar, Robert S. Brown Jr., Yves Horsmans, Shampa De-Oertel, Sarah Arterburn, Hadas Dvory-Sobol, Diana M. Brainard, John G. McHutchison, Norah Terrault, Mario Rizzetto, Beat Müllhaupt
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:Annals of Hepatology
Subjects:
Direct-acting antivirals
NS5B inhibitor
NS5A inhibitor
Decompensated cirrhosis
Liver transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119304107

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119304107

Similar Items